Kindstar Globalgene Technology, Inc.

HKSE 9960.HK

Kindstar Globalgene Technology, Inc. EPS (Diluted) for the year ending December 31, 2023: USD 0.01

Kindstar Globalgene Technology, Inc. EPS (Diluted) is USD 0.01 for the year ending December 31, 2023, a -55.20% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Kindstar Globalgene Technology, Inc. EPS (Diluted) for the year ending December 31, 2022 was USD 0.01, a 102.90% change year over year.
  • Kindstar Globalgene Technology, Inc. EPS (Diluted) for the year ending December 31, 2021 was USD -0.46, a -181.30% change year over year.
  • Kindstar Globalgene Technology, Inc. EPS (Diluted) for the year ending December 31, 2020 was USD -0.16, a -500.81% change year over year.
  • Kindstar Globalgene Technology, Inc. EPS (Diluted) for the year ending December 31, 2019 was USD -0.03, a -222.42% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
HKSE: 9960.HK

Kindstar Globalgene Technology, Inc.

CEO Dr. Shiang Huang
IPO Date July 16, 2021
Location China
Headquarters Biolake D2-1
Employees 3,193
Sector Health Care
Industries
Description

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.

Similar companies

6622.HK

Zhaoke Ophthalmology Limited

USD 0.18

6.04%

2190.HK

Zylox-Tonbridge Medical Technology Co., Ltd.

USD 1.49

0.32%

9959.HK

Linklogis Inc.

USD 0.18

4.39%

StockViz Staff

January 15, 2025

Any question? Send us an email